AblaCor Medical Corporation is an early stage medical device company that is dedicated to the development of revolutionary, minimally invasive products that will transform catheter ablation into a first-line treatment for patients with atrial fibrillation (AFib). Formerly known as Automated Medical Instruments, the company is developing the CircumBlator™ PVI Ablation System. The Company is led by experienced medical device executives and entrepreneurs. Headquartered in Needham, MA, AblaCor is privately held.
Atrial fibrillation presents a significant public health problem for over 2.5 million Americans and over 10 million globally. AFib is a progressive disease that destroys quality of life, causes 15-25% of strokes and is associated with billions of dollars of cost and lost productivity.
Contact Martin J. Sklar, CEO and Founder of AblaCor Medical Corporation by email at msklar@ablacor.com or by phone at 781-248-6841 for more information.
